Universal reference book for medicines
Name of the preparation: OPTIV (OPTIVE)

Active substance: carmellose, glycerol

Type: Corneal protector

Manufacturer: ALLERGAN (United States) manufactured by ALLERGAN SALES (United States)
Composition, form of production and packaging
Eye drops transparent, colorless.
1 ml

carmellose sodium (type 7H3SXF 10-15) 1.75 mg

carmellose sodium (type 7M8SFPH) 3.25 mg

glycerol 9 mg

10 ml - a vial of a dropper (1) - packs cardboard.

15 ml - a vial of a dropper (1) - packs cardboard.


Description of the drug approved by the manufacturer for the printed edition of 2013.


Carmellose sodium and glycerol possess the properties of the corneal epithelium protector, improve the hydration of the cornea with reduced secretion of tear fluid and increase the stability of the tear film.


Studies of pharmacokinetics in humans have not been conducted.


- symptomatic treatment of the "dry eye" syndrome.


The drug is instilled in 1-2 drops in the conjunctival bag as needed.


When using the drug, the development of the following adverse side reactions with the indicated frequency is possible: very often (? 10%), often (? 1%, <10%), infrequently (? 0.1%, <1%);
rarely (? 0.01%, <0.1%), very rarely (<0.01%).
Disorders from the side of the organ of vision: often - congestion hyperemia, eyelid hyperemia, blurred vision, dry eye, discomfort when instilled, itching and irritation of the eyes, crust formation at the edge of the eyelid.

In the postmarketing period, reports of the following undesirable reactions of the drug Optiv® (frequency unknown) were received: pain in the eye area, the appearance of the eye, the sensation of the foreign body in the eye, eyelid edema, increased tearing, photophobia.


- hypersensitivity to the components of the drug;

- Children under 18 years of age (no experience of use).

With caution: during pregnancy and during breastfeeding (due to limited data).


Strictly controlled studies in pregnant women and nursing mothers were not conducted.
In animal studies, adverse effects of the active components of the drug were not detected.
Optic ® is not absorbed from the mucosal surface, so there are no objective prerequisites for the possible excretion of its components with breast milk.

Use of the drug during pregnancy and during lactation is possible with caution.


Contraindicated in children under 18 years.


The drug is intended for topical use only.
Do not use if the integrity of the film, covering the neck of the bottle, clouding the solution or changing its color.
Do not touch the tip of the pipette to any surface, including the conjunctiva, to avoid contamination of the contents of the vial.
It is necessary to close the bottle immediately after using the drug.
The shelf life of the drug after the first opening of the vial is 28 days.
Consult your doctor if you have pain in the eye area, impaired vision, prolonged hyperemia or irritation of the eye mucosa. Also seek advice if there is no improvement from the use of the drug and / or if you have other undesirable effects that build up or are not resolved within 72 hours.
Influence on the management of vehicles and the implementation of potentially hazardous activities

If, after installation, blurring of vision is noted, it is necessary to refrain from driving vehicles and practicing potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions, before it is restored.


Information on cases of overdose of the drug Optiv ® is absent.


There are no data on the drug interaction of the Opto ® preparation.

When appointing with other local ophthalmologic agents, the interval between instillation of the Optiv ® preparation and other eye drops should be at least 5 minutes in order to exclude the possibility of "washing out" the drug.


Without recipe.


At a temperature of no higher than 25 ° C.
Keep out of the reach of children. Shelf life - 2 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!